En cours de chargement...
Get the support you need to safely extend dating of parenteral drugs beyond the usual 24-hour limit - minimizing waste, lowering medication costs, and enabling optimal patient administration schedules at alternate infusion sites. ASHP's sixth edition of Extended Stability for Parenteral Drugs, by Caryn Dellamorte Bing, RPh, MS, FASHP and Anna Nowobilski-Vasilios, PharmD, MBA, FASHP, BCNSP, CNSC, covers all aspects of determining stability, including the changing elastomeric landscape and the ongoing variability in stability data.
An essential reference for anyone involved in sterile compounding or working in alternate-site infusion practice, the sixth edition puts the data you need at your fingertips in 165 drug monographs based on the latest research. Clearly written and designed for quick reference, the monographs are presented in alphabetical order by generic name, with stability data for each drug in various containers, solutions, concentrations, temperature, storage, and administration conditions.
You'll find the most current information for safely extending the use of all the parenteral drugs and biologicals most common to alternate-site infusion practice, with updates to nearly all of the monographs from the fifth edition, as well as 11 new stability monographs on the following medications : ado-trastuzumab emtansine ; blinatumomab ; ceftolozane-tazobactam ; coagulation factor X ; dalbavancin ; ferric carboxymaltose ; ibuprofen lysinate ; iron sucrose ; oritavancin diphosphate ; pertuzumab ; tedizolid phosphate.
Since the publication of the first edition of Extended Stability for Parenteral Drugs in 1991, this book has served an important need in ambulatory pharmacy as the only comprehensive source for reliable stability data on alternate-site infusion products. With its expanded coverage, many updates, and new information, the sixth edition provides even more support, making it a "must have" for any practice in which pharmaceutical solutions are prepared and administered.
